Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.
Publication
, Journal Article
Davidson, JR
Published in: J Clin Psychiatry
2000
Posttraumatic stress disorder (PTSD) is a prevalent and disabling condition. Treatment is essential to reduce symptoms, increase the patient's functioning and well-being, and reduce comorbidity with other psychological disorders. Evidence suggests that psychopharmacologic therapy can be effective in PTSD. This article considers clinical data for various pharmacologic treatment options for PTSD; in particular, several recent studies of selective serotonin reuptake inhibitors are examined. The long-term effects of pharmacotherapy and issues concerning patient management are also discussed.
Duke Scholars
Published In
J Clin Psychiatry
ISSN
0160-6689
Publication Date
2000
Volume
61 Suppl 5
Start / End Page
52 / 56
Location
United States
Related Subject Headings
- Triazoles
- Treatment Outcome
- Stress Disorders, Post-Traumatic
- Serotonin Antagonists
- Selective Serotonin Reuptake Inhibitors
- Psychiatry
- Piperazines
- Paroxetine
- Monoamine Oxidase Inhibitors
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Davidson, J. R. (2000). Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. J Clin Psychiatry, 61 Suppl 5, 52–56.
Davidson, J. R. “Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.” J Clin Psychiatry 61 Suppl 5 (2000): 52–56.
Davidson JR. Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. J Clin Psychiatry. 2000;61 Suppl 5:52–6.
Davidson, J. R. “Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.” J Clin Psychiatry, vol. 61 Suppl 5, 2000, pp. 52–56.
Davidson JR. Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. J Clin Psychiatry. 2000;61 Suppl 5:52–56.
Published In
J Clin Psychiatry
ISSN
0160-6689
Publication Date
2000
Volume
61 Suppl 5
Start / End Page
52 / 56
Location
United States
Related Subject Headings
- Triazoles
- Treatment Outcome
- Stress Disorders, Post-Traumatic
- Serotonin Antagonists
- Selective Serotonin Reuptake Inhibitors
- Psychiatry
- Piperazines
- Paroxetine
- Monoamine Oxidase Inhibitors
- Humans